Confirm PCA-9000A PET/CT System is Effective for Its Intended Use
Conditions
Brief summary
The purpose of this study will evaluate new technologies that have been included in the new PCA-9000A PET/CT System.
Detailed description
Scope: To evaluate the new technologies that have been included in the PCA-9000A PET/CT System, the study has the following 3 goals. * Define and confirm all supported clinical protocols from Low-Dose CT, to PET acquisition and presentation. * Verification of the quantitative accuracy of the imaging chain. * Evaluate the performance and stability of the new system and its related quality control and calibration procedures. Result (Expected): The study is an essential step in assessing the quality of the hardware and software defining the new PCA-9000A PET/CT System. Several essential parameters for the acquisition, reconstruction, correction, filtering, and presentation will be estimated or adjusted during this period. The evaluation will confirm PCA-9000A PET/CT System is effective for its intended use.
Interventions
None listed
Sponsors
Toshiba America Medical Systems, Inc.
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
40 Years to No maximum
Inclusion criteria
Inclusion: * Patients already scheduled for an FDG test at SDMI * 40 years and older * Adult must be able to sign an informed consent form Exclusion * Patients not scheduled for an FDG test at SDMI * 39 years or younger * Pregnant adult female or plan to be pregnant * Adult who is unable to sign the informed consent
Countries
United States
Outcome results
None listed